Table 1 |
|
| Patient demographic and clinical data | |
| Variables | Statistics |
| Age (y) | 57.00 ± 13.82 |
| Lymph node ratio | 0.05 ± 0.10 |
| Survival duration (months) | 61.69 ± 17.20 |
| DFS duration (month) | 56.33 ± 23.38 |
| Gender | |
| Male | 32 (59.3) |
| Female | 22 (40.7) |
| Location of tumor | |
| Colon | 28 (51.9) |
| Rectum | 26 (48.1) |
| Depth of invasion | |
| T1 | 2 (3.7) |
| T2 | 8 (14.8) |
| T3 | 21 (38.9) |
| T4 | 23 (42.6) |
| Stage | |
| I | 7 (13.0) |
| II | 25 (46.3) |
| III | 22 (40.7) |
| Death | 13 (24.1) |
| Recurrence or metastasis | 14 (25.9) |
DFS, disease free survival; HE, hematoxylin-eosin; SLN, sentinel lymph node.
Continuous variables were shown as mean ± standard deviation and categorical variables were presented as number (%).
Wang et al. Diagnostic Pathology 2012 7:71 doi:10.1186/1746-1596-7-71
